The parkinson's complex: Parkinsonism is just the tip of the iceberg

A 78-year-old man presented with a 15-year history of chronic constipation. At age 68, he experienced a nearcomplete loss of his sense of smell. Recently, he has developed an unusual sleep disorder, characterized by abrupt and at times combative behavior during the night that has resulted in injury to his spouse on two separate occasions; he is referred to a sleep disorders clinic. For most physicians, this medical history would not immediately bring Parkinson’s disease (PD) to mind. Yet, accumulating clinical and pathological evidence suggests it should. The traditional “textbook” description of PD defines the disease as a progressive disorder characterized by the triad of rigidity, bradykinesia, and rest tremor. A large body of evidence suggests that these features are due to degeneration of the dopaminergic nigrostriatal system. Although these clinical features typically lead a patient to the door of the neurologist, it is now increasingly clear that parkinsonism is only one aspect of a multifaceted and complex disorder. Furthermore, it is increasing clear that at least some of these nonparkinsonian features can precede the onset of parkinsonism by years and perhaps even decades. This essay argues that parkinsonism represents the disease as seen through the somewhat myopic lens of the neurologist, whereas in reality, parkinsonism only represents the tip of the iceberg that makes up this diverse disease (Fig 1). If one accepts this view, then the time has come to radically rethink the complex of features that constitute the disorder, which might be better viewed as a “centrosympathomyenteric neuronopathy.” The implications of this thesis are of more than academic importance. A failure to reevaluate how we view this disease at a time when our knowledge about its clinical and pathological features is expanding rapidly will adversely affect not only efforts to improve the diagnosis and management of the patients that we care for, but also is likely to impede research into the cause of the disease and attempts to slow or halt its progression.

[1]  F. Lewy Paralysis agitans. I. Pathologische Anatomie , 1912 .

[2]  Cecil M. Burchfiel,et al.  Environmental, life-style, and physical precursors of clinical Parkinson’s disease: recent findings from the Honolulu-Asia Aging Study , 2003, Journal of Neurology.

[3]  J. Parkinson An Essay on the Shaking Palsy , 2002 .

[4]  I. Bodis-Wollner,et al.  Parkinson's disease and nonmotor dysfunction , 2005 .

[5]  H. Reichmann,et al.  Olfactory function in idiopathic Parkinson's disease (IPD): results from cross-sectional studies in IPD patients and long-term follow-up of de-novo IPD patients , 2002, Journal of Neural Transmission.

[6]  A. Colcher,et al.  Manometric abnormalities of the oesophagus in patients with Parkinson’s disease , 2001, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[7]  Mark W. Mahowald,et al.  Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder , 1996, Neurology.

[8]  J. Parkinson AN ESSAY ON THE SHAKING PALSY , 1969 .

[9]  C. Tanner,et al.  Excessive daytime sleepiness and subsequent development of Parkinson disease , 2005, Neurology.

[10]  A. Johnson,et al.  Olfactory function in patients with Parkinson's disease. , 1975, Journal of chronic diseases.

[11]  E. Quigley,et al.  Anorectal manometry in the assessment of anorectal function in Parkinson's disease: A comparison with chronic idiopathic constipation , 1994, Movement disorders : official journal of the Movement Disorder Society.

[12]  J. Greenfield,et al.  THE BRAIN-STEM LESIONS IN PARKINSONISM , 1953, Journal of neurology, neurosurgery, and psychiatry.

[13]  E. Herzog Histopathologische Veränderungen im Sympathicus und ihre Bedeutung , 1928, Deutsche Zeitschrift für Nervenheilkunde.

[14]  Satoshi Orimo,et al.  Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease , 2005, Acta Neuropathologica.

[15]  J. Obeso,et al.  Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough , 2004, The Lancet Neurology.

[16]  Hansjürgen Bratzke,et al.  Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages) , 2002, Journal of Neurology.

[17]  Marsden Cd Neuromelanin and Parkinson's disease. , 1983 .

[18]  H. Braak,et al.  α-Synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei , 2001, Acta Neuropathologica.

[19]  W. Oertel,et al.  Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. , 2004, Brain : a journal of neurology.

[20]  Hitoshi Takahashi,et al.  Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses , 2004, Acta Neuropathologica.

[21]  S. Morgello,et al.  The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature , 1997, Acta Neuropathologica.

[22]  K. Iwanaga,et al.  Lewy body–type degeneration in cardiac plexus in Parkinson’s and incidental Lewy body diseases , 1999, Neurology.

[23]  D. Woitalla,et al.  3-OMD and homocysteine plasma levels in parkinsonian patients , 2002, Journal of Neural Transmission.

[24]  J. Carrier,et al.  REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease , 2002, Neurology.

[25]  M. Uchiyama,et al.  Incidental Lewy body disease in a patient with REM sleep behavior disorder , 1995, Neurology.

[26]  C. Marsden Neuromelanin and Parkinson's disease. , 1983, Journal of neural transmission. Supplementum.

[27]  C. Tranchant Parkinson's disease and nonmotor dysfunction , 2006 .